Subscribe To
How to comfort a dog with congestive heart failure
Dogs with congestive heart failure (CHF) experience a multitude of discomforting symptoms. They may bec...
November 1, 2023, 5:44 pm
Understanding the symptoms of congestive heart failure
Share on Pinterest Iuliia Burmistrova/Getty Images Congestive heart failure (CHF) affects your heart’s ability to pump enough blood to effectively m...
October 27, 2023, 6:14 pm
Ardelyx shares positive data on symptom response during treatment with ibsrela® (tenapanor) for ibs-c and hosts ibs-c product theater at acg 2023
WALTHAM, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, devel...
October 23, 2023, 12:07 pm
Pfizer will charge up to $1,400 for covid drug paxlovid
The pill is designed to treat Covid-19 in adults and pediatric patients with a high risk for developing severe ...
October 18, 2023, 8:48 pm
Gynesonics’ incision-free sonata procedure for the treatment of uterine fibroids reaches patient milestones in the u.s. and globally
REDWOOD CITY, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) — Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally inv...
October 17, 2023, 4:00 pm
Vitamins & supplements center
Considering taking a vitamin or supplement to treat Congestive+Heart Failure (Chf)? Below is a list of common natural remedies used to treat or reduce...
October 16, 2023, 7:29 pm
Aldeyra therapeutics stock tanks on warning that fda will reject new drug application
Shares of Aldeyra Therapeutics (NASDAQ:ALDX) have lost two-thirds of their value Monday after the company warned the US Food and Drug Administration m...
October 16, 2023, 11:27 am
Axsome update: buy at dips and hold forever
Axsome Therapeutics' Auvelity is experiencing strong sales growth in the Major Depressive Disorder space, with sales of $27.6 million in the last quar...
October 16, 2023, 6:11 am
Merakris announces nationwide at-your-door autologous serum tears program
Extends Reach of Therapy for Dry Eye and Other Ocular Surface Disease symptoms RESEARCH TRIANGLE PARK, ...
October 12, 2023, 10:30 am
Eli lilly stock hits new high on positive crohn's disease study results
Eli Lilly and Co (NYSE:LLY) announced on Thursday that its drug development candidate, mirikizumab, met the main goals of a late-stage study to test...
October 12, 2023, 8:35 am
Kalvista's sebetralstat: a pill worth swallowing in hae
KalVista Pharmaceuticals is positioned to disrupt the HAE treatment landscape with its oral therapy, sebetralstat, offering rapid ...
October 1, 2023, 12:05 am
Bionomics shares soar almost 400% after positive phase iib results from ptsd treatment
Shares of Bionomics Limited rocketed 387% after phase IIb trial results showed its lead asset had the potential to become a best-in-class treatment fo...
September 28, 2023, 10:00 am
4 stages of congestive heart failure: what each stage means
Congestive heart failure (CHF) is a condition in which the heart isn’t able to effectively pump blood to the body, leading to ...
September 25, 2023, 9:16 pm
Reasons for another bitcoin bull run
Cryptocurrency aficionados and investors have been keenly following the moves of Bitcoin, the digital currency market's pioneer and bellwether. Bitcoi...
September 19, 2023, 12:34 pm
Pharmazz inc. and sun pharma enter into licensing agreement for introducing tyvalzi™ (sovateltide) in india
Sovateltide is a first of its kind drug to treat acute cerebral ischemic stroke that can be administered up to 24 hours after the onset of ...
September 14, 2023, 4:30 am
Covid-19 diagnostics market revenue to cross usd 45.8 billion by 2031, registering a negative 7.9% cagr says, transparency market research
An increase of COVID-19 instances and related symptoms is anticipated to fuel market growth. During the...
September 13, 2023, 10:20 am
Acelyrin stock collapses after skin drug trail failure
Acelyrin Inc (NASDAQ:SLRN) collapsed, down some 58% ahead of Tuesday's open, after the company revealed the failure of its clinical trial which attemp...
September 12, 2023, 9:08 am
Acelyrin tumbles after skin disease drug fails key trial
Shares of drug developer Acelyrin slumped 57% in premarket trading on Tuesday after the company's experimental lead drug failed to show it was effecti...
September 12, 2023, 6:46 am
Crinetics’ once-daily oral paltusotine achieved the primary and all secondary endpoints in the phase 3 pathfndr-1 study evaluating treatment of patients with acromegaly
83% of Participants on Paltusotine Maintained IGF-1 ≤1.0 xULN vs. 4% on placebo (p<0.0001) Mean IGF-1 Levels Were Maintained on Paltusotine vs. an I...
September 10, 2023, 2:00 pm
Okyo pharma completes enrollment in phase 2 clinical trial to treat dry eye disease
OKYO Pharma Ltd (NASDAQ:OKYO) announced that it has completed full enrollment of patients in the randomized portion of the Phase 2 multi-center, doubl...
September 8, 2023, 8:35 am